Even if they do issue shares to raise money again, at some point in the future, that's much better (for both the company, and the shareholders,) than getting more toxic financing on terrible terms. What do shareholders think, that R&D companies don't need financing? A realistic view shows that this company does need, and well deserves, financing. It's a very promising company, extremely promising in my view, their main problem (aside from full-time bashing and simultaneous manipulation that's driven this stock down into the dirt!) is simply that they need financing (though their cost-cutting measures could conceivably turn things around, in conjunction with growing their existing income streams.) If they issue more stock, those who believe in the potential and value of this company, would do best to simply buy more shares, especially if they get cheaper. Right now, CHEAP is an understatement.
A healthy dose of realism is needed, here. Also, the SEC really needs to crack down on the industrial-scale, extremely blatant, bashing and manipulation. The bashing and manipulation is what has gutted the share price. Manufactured fear has created a ridiculous situation, here. Success is not built on paranoia and fear. Some "investors" are distinctly paranoid, and penny-wise, pound-foolish. A company doesn't need "investors" like those. Great companies are built on solid foundations, that allow them to grow into their potential. The potential of DNAPrint Genomics is enormous, certainly much greater than recent share price would seem to indicate. A reality check, and an analysis of consequences of attitudes/statements/actions, is definitely in order.
Some cogent analogies could be stated, here, such as: someone in a burning building would do well to avoid pouring gasoline around the building, and also would do well to avoid scaring those who are holding the trampoline, to catch people. Such behaviors are nonsensical and harmful. In the context of securities, like DNAG, such behavior is also unlawful. It is not lawful to create false impressions to manipulate share price, nor is it legal to conduct blatant direct manipulation of share price, as we have seen done so blatantly, so many times. We need change. Not more of the same. And I don't mean change from DNAPrint Genomics.
